T Hussey, Africa Athanasius, George Mbogo, Brenda Mccoard et al.
Sarah Laing, Isabel Dye, R L Byrne, Eva Freckmann et al.
Although 30-40% of human Non-Small Cell lung cancers show low level amplification of c-MYC and genetic evidence supports c-Myc as a key downstream effector of KRas-driven tumourigenesis in mouse models, the functional contribution of MYC to human lung cancer remains unclear. We applied a phenotype-b...